Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KRX/069620 stock hub

KRX/069620 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/069620is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.7T

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/069620

In the news

Latest news · KRX/069620

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E10.1

P25 9.8P50 17.1P75 31.9

Trailing P/E8.5

P25 12P50 23.1P75 39.5

ROE18.4

P25 -17.1P50 0.7P75 8.5

ROIC11.5

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/069620 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

236

Groups with data

Currency

KRW

Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	1,644
Enterprise value	KRW 2.5T
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KR7069620003
Last refreshed	2026-05-10
Market cap	KRW 1.7T
Price	KRW 145,200
Price currency	KRW
Rev Per Employee	955,529,808.59x
Sector	Healthcare
Sic	2834
Symbol	krx/069620
Website	https://www.daewoong.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	11.72%
EV Earnings	12.54x
EV/EBIT	10.16x
EV/EBITDA	8.39x
EV/FCF	-58.02x
EV/Sales	1.56x
FCF yield	-2.53%
Forward P/E	10.08x
P/B ratio	1.47x
P/E ratio	8.53x
P/S ratio	1.06x
PE Ratio10 Y	61.15x
PE Ratio3 Y	22.41x
PE Ratio5 Y	65.03x
PEG ratio	1.6x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	12.45%
EBITDA Margin	15.7%
Gross margin	52.36%
Gross Profit	KRW 822.5B
Gross Profit Growth	12.04%
Gross Profit Growth Q	10.88%
Gross Profit Growth3 Y	8.83%
Gross Profit Growth5 Y	13.02%
Net Income	KRW 195.9B
Net Income Growth	691.83%
Net Income Growth Quarters	4%
Net Income Growth Years	1%
Net Income Growth3 Y	66.75%
Net Income Growth5 Y	72.69%
Pretax Margin	12.21%
Profit Margin	12.47%
Profit Per Employee	KRW 119.1M
Profitable Years	7
ROA	5.63
Roa5y	4.61
ROCE	11.02
ROE	18.4
Roe5y	8.98
ROIC	11.45
Roic5y	9.07

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	5.63%
Cagr15y	10%
Cagr1y	6.83%
Cagr20y	8.37%
Cagr3y	8.89%
Cagr5y	0.67%
Div CAGR10	0%
Div CAGR3	0%
Div CAGR5	0%
EPS Growth	691.8
EPS Growth Quarters	4
EPS Growth Years	1
EPS Growth3 Y	64.61
EPS Growth5 Y	70.08
OCF Growth	189.76%
OCF Growth Q	78.64%
OCF Growth10 Y	15.31%
OCF Growth3 Y	8.07%
OCF Growth5 Y	8.12%
Revenue Growth	10.42x
Revenue Growth Q	7.95x
Revenue Growth Quarters	20x
Revenue Growth Years	5x
Revenue Growth3 Y	7.06x
Revenue Growth5 Y	8.28x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.72
Assets	KRW 2.4T
Cash	KRW 172.8B
Current Assets	KRW 732.4B
Current Liabilities	KRW 588.8B
Debt	KRW 829.4B
Debt EBITDA	KRW 3.36
Debt Equity	KRW 0.73
Debt FCF	KRW -19.59
Equity	KRW 1.1T
Interest Coverage	15.67
Liabilities	KRW 1.2T
Long Term Assets	KRW 1.6T
Long Term Liabilities	KRW 639.3B
Net Cash	KRW -656.6B
Net Cash By Market Cap	KRW -39.3
Net Debt EBITDA	KRW 2.66
Net Debt Equity	KRW 0.58
Tangible Book Value	KRW 867.1B
Tangible Book Value Per Share	KRW 75,362
WACC	3.49

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.24
Inventory Turnover	2.64
Net Working Capital	KRW 248.7B
Quick ratio	0.66
Working Capital	KRW 143.5B
Working Capital Turnover	KRW 19.4

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	KRW 600
Dividend Years	23
Dividend Yield	0.41%
Ex Div Date	2025-12-29
Last Dividend	KRW 600
Payout Frequency	Annual
Payout Ratio	4.12%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	72.95%
1Y total return	6.82%
200-day SMA	156,984
3Y total return	29.11%
50-day SMA	157,980
50-day SMA vs 200-day SMA	50over200
5Y total return	3.38%
All Time High	286,500
All Time High Change	-49.32%
All Time High Date	2020-12-22
All Time Low	10,552.3
All Time Low Change	1,276.01%
All Time Low Date	2003-03-11
ATR	4,936.5
Beta	0.07
Beta1y	-0
Beta2y	0.16
Ch YTD	-15.73
High	147,600
High52	199,400
High52 Date	2025-12-11
High52ch	-27.18%
Low	143,000
Low52	128,900
Low52 Date	2025-08-12
Low52ch	12.65%
Ma50ch	-8.09%
Price vs 200-day SMA	-7.51%
RSI	39.96
RSI Monthly	50.14
RSI Weekly	40.21
Sharpe ratio	0.38x
Sortino ratio	0.75
Total Return	0.41%
Tr YTD	-15.73
Tr15y	317.75%
Tr1m	-2.75%
Tr1w	-1.69%
Tr3m	-11.08%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 195.5B
Operating Income Growth	34.61
Operating Income Growth Q	16.88
Operating Income Growth3 Y	26.84
Operating Income Growth5 Y	63.02
Operating margin	12.45

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,379,031%
Net Borrowing	172,761,374,330
Shares Insiders	0.45%
Shares Institutions	25.56%
Shares Out	11,506,270
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -42.8B
Average Volume	31,228.95x
Bv Per Share	87,438.7
CAPEX	KRW -191.5B
Ch10y	65.19
Ch15y	270.3
Ch1m	-2.75
Ch1w	-1.69
Ch1y	6.45
Ch20y	315.3
Ch3m	-11.08
Ch3y	27.37
Ch5y	1.19
Ch6m	3.94
Change	0.28%
Change From Open	-0.82
Close	144,800
Days Gap	1.1
Depreciation Amortization	51,072,449,000
Dollar Volume	5,773,442,400
Earnings Date	2026-05-15
EBIT	KRW 195.5B
EBITDA	KRW 246.6B
EPS	KRW 17,022
F Score	5
FCF	KRW -42.3B
FCF EV Yield	-1.72x
FCF Per Share	KRW -3,679
Financing CF	164,352,037,100
Fiscal Year End	December
Founded	1,945
Goodwill	60,848,079,000
Graham Number	182996.92864
Graham Upside	26.03
Income Tax	KRW -1.1B
Investing CF	-247,026,350,140
Is Primary Listing	1
Last Earnings Date	2026-02-09
Last Report Date	2025-12-31
Last Split Date	2012-12-27
Last Split Type	Forward
Lynch Fair Value	KRW 425,541
Lynch Upside	193.1
Ma150	160,967.3
Ma150ch	-9.8%
Ma20	149,895
Ma20ch	-3.13%
Net CF	65,991,221,230
Next Earnings Date	2026-05-15
Open	146,400
P OCF Ratio	11.2
Payment Date	2026-04-10
Position In Range	47.83
Ppne	842,341,424,990
Price Date	2026-05-08
Price EBITDA	KRW 6.78
Ptbv Ratio	1.93
Relative Volume	1.27x
Revenue	1,570,891,005,320x
SBC By Revenue	0.03x
Share Based Comp	475,961,000
Tax By Revenue	-0.07x
Tr20y	399.15%
Tr6m	4.3%
Volume	39,762
Z Score	2.32

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

KRX/069620 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.4%

$600 annual per share

Payout ratio

+4.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

0.0%

0 consecutive years of growth

Total shareholder yield

+0.4%

Next ex-dividend date: 2025-12-29

Performance

KRX/069620 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/069620?

Insider, institutional, and short-interest positioning.

Institutional ownership

+25.6%

Share of float held by funds and institutions

Insider ownership

+0.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

KRX/069620 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.0

Neutral momentum band

Price vs 200-day MA

-7.5%

50/200-day relationship not available

Beta (5Y)

0.07

Less volatile than the market

Sharpe ratio

0.38

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/069620

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/069620 stock rating?

krx/069620 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/069620 analysis?

The full report lives at /stocks/krx/069620/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/069620?

The latest report frames krx/069620 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/069620 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.